Effect of Tenofovir (TDF) on Renal Function in Patients With Chronic Hepatitis B
Trial statusNot yet recruiting
Trial phaseNot listed
Trial typeObservational
Biological sexAll
Age18-60
SponsorAssiut University
About this trial
Effect of Long-Term Use of Tenofovir (TDF) on Renal Function in Patients with Chronic Hepatitis B Over a Five-Year Period
Eligibility criteria
This trial does not accept healthy volunteersQualifiers
None
Disqualifiers
None
Trial population
Study Population Age Range: 18 to 60 years Sex: Male and Female HBV Status: HBV-positive patients Treatment Duration: Long-term use of Tenofovir (TDF) for more than five years Sampling Method: Non-Probability Sampling Healthy Volunteers: Not Accepted
Trial design
Design model
Cohort
Time perspective
Prospective
Treatments tested in this trial
Tenofovir Disoproxil Fumarate (TDF)
DrugANTIVIRAL TREATMENT FOR CHRONIC HEPATITIS B VIRUS INFECTION
Treatment groups
No treatment groups listed
Trial outcomes
Primary outcomes
1
Changes in eGFR in Patients on Long-Term Tenofovir (TDF) Therapy
"Renal function will be assessed using estimated glomerular filtration rate (eGFR) calculated by the CKD-EPI equation
Time frame
BASELINE2
Assessment of Renal Function: Serum Creatinine in Patients on Long-Term Tenofovir (TDF) Therapy
"Renal function will be assessed using serum creatinine levels measured through standard laboratory assays.
Time frame
BASELINE3
proteinuria will be evaluated through urine protein-to-creatinine ratio
proteinuria will be evaluated through urine protein-to-creatinine ratio (if applicable).
Time frame
BASELINESponsors and contacts
Click on the lead sponsor to view all of their trials.
Source ClinicalTrials.gov
This trial is not recruiting at the moment. You can still explore other options: